Literature DB >> 9264173

Schizophrenia, rheumatoid arthritis and natural resistance genes.

G Rubinstein1.   

Abstract

The strong negative correlation between schizophrenia and rheumatoid arthritis might provide clues as to the aetiology of these two diseases. An immunological explanation has been sought in the HLA sector of the major histocompatibility complex, which has been shown to have a role in the development of rheumatoid arthritis. The search for an association between schizophrenia and HLA haplotypes, however, has yielded only controversial results. Nevertheless, an autoimmune aetiology is still suspected. The recent demonstration of geographical co-occurrence of high rates of schizophrenia and flavivirus infection suggests, for the first time, that a natural resistance gene (NRG) might be involved in the aetiology of schizophrenia. Such a NRG is carried by the C3H/RV mouse, providing protection against lethal infection by flavivirus, but not by the histocompatible C3H/He mouse. Furthermore, the C3H/He mouse has proved to be a good model for the development of Lyme arthritis, resulting from infection by Borrelia burgdorferi. It is suggested that there is a possibility that the C3H/RV mouse, which is known to be resistant to both flavivirus and rickettsia, may also be resistant to borrelia, since the Ixodid tick vector of flavivirus is the vector for all three of these organisms. If so, then the C3H/RV mouse would resist infection by borrelia, and could not develop Lyme arthritis. It is hypothesised, therefore, that despite the histocompatibility of these two strains, while the C3H/He mouse is vulnerable to Lyme arthritis, the C3H/RV mouse may be resistant. As a consequence, NRGs may play a part in triggering autoimmune disease, with HLA antigens responsible for its further development. This would indicate that the negative association of schizophrenia and rheumatoid arthritis could result from resistance or vulnerability to certain infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9264173     DOI: 10.1016/s0920-9964(97)00023-6

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

Review 1.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Paradox of schizophrenia genetics: is a paradigm shift occurring?

Authors:  Nagafumi Doi; Yoko Hoshi; Masanari Itokawa; Takeo Yoshikawa; Tomoe Ichikawa; Makoto Arai; Chie Usui; Hirokazu Tachikawa
Journal:  Behav Brain Funct       Date:  2012-05-31       Impact factor: 3.759

Review 3.  Theories of schizophrenia: a genetic-inflammatory-vascular synthesis.

Authors:  Daniel R Hanson; Irving I Gottesman
Journal:  BMC Med Genet       Date:  2005-02-11       Impact factor: 2.103

Review 4.  Epidemiology and genetics of rheumatoid arthritis.

Authors:  Alan J Silman; Jacqueline E Pearson
Journal:  Arthritis Res       Date:  2002-05-09

Review 5.  Major Histocompatibility Complex I Expression by Motor Neurons and Its Implication in Amyotrophic Lateral Sclerosis.

Authors:  Giovanni Nardo; Maria Chiara Trolese; Caterina Bendotti
Journal:  Front Neurol       Date:  2016-06-13       Impact factor: 4.003

6.  A nationwide study of the risks of major mental disorders among the offspring of parents with rheumatoid arthritis.

Authors:  Hsien-Jane Chiu; Cheuk-Kwan Sun; Shih-Jen Tsai; Ya-Mei Bai; Kuo-Chuan Hung; Ju-Wei Hsu; Kai-Lin Huang; Tung-Ping Su; Tzeng-Ji Chen; Andrew Sun; Yu-Shian Cheng; Mu-Hong Chen
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.